This inventor holds 1 USPTO granted patent. Top assignee: Masarykova Univerzita. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Jiri Mayer - Innovator in Chronic Lymphocytic Leukemia Research
Introduction
Jiri Mayer is a notable inventor based in Brno, Czech Republic. He has made significant contributions to the field of medical diagnostics, particularly in the area of B-cell chronic lymphocytic leukemia (CLL). His innovative work has led to the development of a method that aids in the diagnosis and prognosis of this disease.
Latest Patents
Jiri Mayer holds a patent for a method of determination of diagnosis and prognosis in patients with B-cell chronic lymphocytic leukemia. This invention provides a method for determining the diagnosis and prognosis of CLL from a biological sample collected from a patient. The method involves assessing the status of the Wnt/PCP signaling pathway, which has been found to be markedly up-regulated in B-lymphocytes of patients suffering from CLL. The patent also includes suitable oligonucleotides for use in this diagnostic method.
Career Highlights
Jiri Mayer is affiliated with Masaryk University, where he continues to engage in research and development in the field of oncology. His work has been instrumental in advancing the understanding of CLL and improving diagnostic techniques.
Collaborations
Jiri Mayer has collaborated with notable colleagues such as Pavel Krejci and Sarka Pospisilova. Their joint efforts have contributed to the advancement of research in the field of chronic lymphocytic leukemia.
Conclusion
Jiri Mayer's innovative contributions to the diagnosis and prognosis of B-cell chronic lymphocytic leukemia highlight his importance in the medical research community. His work not only enhances the understanding of this disease but also paves the way for improved patient outcomes.